VSee Health Reports 48% Revenue Growth but Faces Increased Losses in Q2 2026

VSee Health, Inc. reported its financial results for the second quarter of 2026, revealing a total revenue of $1.56 million, a 48% increase from $1.06 million in the same period last year. For the first half of 2026, revenue reached $3.44 million, up 53% from $2.25 million in the prior year. The growth was primarily driven by increased telehealth and patient fees, which rose significantly due to expanded service offerings and contracts with larger hospital networks. However, the company also faced a substantial increase in costs, with cost of revenues soaring to $1.36 million for the quarter, compared to $440,147 in the previous year, leading to a gross margin decline.

The company's operating expenses for the second quarter were $2.90 million, a 34% increase from $2.17 million in the prior year. This rise was attributed to higher compensation costs and general administrative expenses, including increased bad debt expenses and legal fees. As a result, VSee Health reported a net loss of $3.08 million for the quarter, compared to a loss of $1.90 million in the same period last year. For the first half of 2026, the net loss was $4.34 million, a decrease from $5.54 million in the first half of 2025.

In terms of operational metrics, VSee Health's customer base and service engagement have shown positive trends. The company has successfully expanded its telehealth services, particularly in teleradiology, which has seen a significant increase in revenue. However, the company also reported challenges, including a decline in revenue from its Tele-ICU services due to client attrition. As of June 30, 2026, VSee Health had 56.68 million shares of common stock outstanding, reflecting a significant increase from the previous year.

Strategically, VSee Health divested its subsidiary, VSee Lab, on May 31, 2026, which has been classified as a discontinued operation. This move is part of the company's efforts to streamline operations and focus on its core telehealth services. The divestiture resulted in a gain of $4.17 million, which positively impacted the financial results from discontinued operations. Looking ahead, VSee Health is actively pursuing additional financing options and exploring new market opportunities to enhance its liquidity and support future growth initiatives.

The company has expressed concerns regarding its ability to continue as a going concern, citing liquidity issues and historical operating losses. Management is implementing revenue enhancement strategies and seeking new contracts to improve financial stability. The outlook remains cautious, with the company acknowledging the need for additional funding to address its operational challenges and continue its growth trajectory in the evolving telehealth market.